Innate Pharma SA
1.7120
08-四月-25 11:29:31
15 分钟延时
股票
+0.0460
+2.76%
今日范围
1.6880 - 1.7500
ISIN
FR0010331421
来源
Cboe
-
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
21 4月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
19 4月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Innate Pharma reports Full Year 2020 financial results and business update
18 3月 2021 02:00:00 条件 Nasdaq GlobeNewswire
-
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
16 3月 2021 02:00:00 条件 Nasdaq GlobeNewswire
-
Number of shares and voting rights of Innate Pharma as of February 1, 2021
24 2月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
17 2月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Innate Pharma advances lacutamab clinical development program
09 2月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
03 2月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Innate's first NK cell engager selected by Sanofi as drug candidate for development
05 1月 2021 01:00:00 条件 Nasdaq GlobeNewswire
-
Innate Pharma to participate in upcoming investor conferences
04 1月 2021 01:00:00 条件 Nasdaq GlobeNewswire